SSAA09E2 |
SARS-CoV |
Small molecule |
Disturbing S-ACE2 interaction |
PPII of S-ACE2 complex |
[75] |
VE607 |
SARS-CoV |
[76] |
Methylene blue |
SARS-CoV-2 |
[77] |
Diammonium Glycyrrhizinate |
SARS-CoV-2 |
[78] |
corilagin |
SARS-CoV-2 |
[79] |
CB6 |
SARS-CoV-2 |
Antibody |
[80] |
B38 |
SARS-CoV-2 |
[81] |
311mab-31B5 and 311mab-32D4 |
SARS-CoV-2 |
[85] |
COVA2-15 |
SARS-CoV-2 |
[86] |
IgG1 ab1 |
SARS-CoV-2 |
[87] |
hrsACE2 |
SARS-CoV-2 |
Soluble peptide analogues of ACE2 |
[83] |
ACE2-Ig |
SARS-CoV-2 |
[88] |
EK1C4 |
SARS-CoV-2 |
Lipopeptide |
Disturbing 6-HB formation of S protein |
S protein |
[90] |
Arbidol |
SARS-CoV-2 |
Small molecule |
Modulating S protein trimerization |
[96], [127]
|
S471-503 |
SARS-CoV |
Soluble peptide analogues of S |
Disturbing S-ACE2 interaction |
host ACE2 |
[97] |
438YKYRYL443 |
SARS-CoV |
host ACE2 |
[98] |
Chloroquine |
SARS-CoV-2 |
Small molecule |
atypical PPI inhibition |
[105] |
Octapeptide |
SARS-CoV-2 |
Peptide-based inhibitor |
Disturbing intra-dimer of 3CLpro |
3C-like protease |
[108], [109]
|
P3 |
SARS-CoV-2 |
Small molecule |
Stabilizing a non-native dimer of N-NTD |
Nucleocapsid protein |
[113] |